Immunic to Participate in Investor and Scientific Conferences in September
(NASDAQ:IMUX) NEW YORK, Sept. 4, 2025 /PRNewswire/ -- Immunic, Inc. (Nasdaq: IMUX), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chron...
3 days ago